Better Analysis for Better Decisions

Helping life sciences innovators navigate complexity and realize opportunities

Get Started!
Publications

Publications

Wing Tech is an international technology and management consulting firm specializing in health-economic evidence development and strategic analysis for innovators in the global life sciences and medical technology sectors.

With more than two decades of experience, Wing Tech combines rigorous analytical methodologies with deep clinical and industry expertise to support evidence-based decision-making throughout the technology lifecycle. The firm serves a diverse client base, including Fortune 500 medical technology companies, leading research institutions, investors, and emerging life sciences ventures.

Expertise

Wing Tech’s expertise and project experience span a broad range of clinical indications, diagnostic and therapeutic technologies, and healthcare systems worldwide.

Methodology

Wing Tech applies rigorous analytical methodologies to generate evidence and inform strategic decision-making throughout the lifecycle of life sciences innovation.

Insights

Wing Tech’s peer-reviewed publications and scientific conference presentations contribute evidence and insights to inform clinical, economic, and strategic decision-making.

Transcatheter versus Surgical Aortic Valve Replacement

A health-economic analysis found transcatheter aortic valve replacement (TAVR) to be a cost-effective alternative to surgical valve replacement among patients at low surgical risk in the UK healthcare system.

Spotlights

Meta-analysis of endovascular treatment of long lesions presented at SCAI 2025

May 3, 2025, Washington DC: Study lead author Dr. Sameh Sayfo (Baylor Scott & White Legacy Heart Center, Plano, TX) presented on the findings of a Wing Tech-led systematic search and meta-analysis of outcomes of endovascular treatment of long ...

Podium presentation at EuroPCR in Paris/France

May 2025, Paris, France: Prof. Andrew Sharp (University College Dublin, Ireland) will present “Cost-effectiveness of radiofrequency renal denervation in five European countries” at a session at EuroPCR 2025, the world-leading course in interve...

Cost-Effectiveness Analysis of Renal Denervation for Hypertension in Sweden published in Blood Pressure

April 11, 2025, Blood Pressure: A country-specific cost-effectiveness analysis of radiofrequency renal denervation for Sweden has been published in Blood Pressure. The study, co-authored by Professors Thomas Kahan and Peter Lindgren (Karolinska I...

Society of Interventional Radiology (SIR) ‘Abstracts of the Year’ presentation at SIR 2025 Annual Scientific Meeting, Nashville, TN

April 2, 2025, Nashville, TN: Study co-author Dr. Nicholas J. Petruzzi, MD, FSIR presented “One-Year Clinical and Lifetime Cost-Effectiveness Outcomes of Transcatheter Arterialization for No-Option CLTI in the U.S.” at the SIR 2025 Annual Meet...

Renal Denervation Study Presentation at EuroPCR

May 19, 2022, Paris, France: “Projected Clinical Events Avoided in Patients Treated with Renal Denervation” to be presented by Prof. Roland Schmieder based on Wing Tech-developed analysis model. EuroPCR. http://pcronline.com/

CVIR Publication on Drug-Coated Balloons

Jan. 4, 2022: Study “Cost-Effectiveness of Urea Excipient-Based Drug-Coated Balloons for Chronic Limb-Threatening Ischemia from Femoropopliteal Disease in the Netherlands and Germany” published in Cardiovascular and Interventional Radiology.